Advertisement

Topics

Astex Pharma’s Leukemia Drug Fails Clinical Trial

20:00 EDT 30 Jul 2018 | BioSpace

Astex Pharmaceuticals, a member of the Otsuka group of companies, and Otsuka Pharmaceutical, indicated their guadecitabine (SGI-110) missed its co-primary endpoints in acute myeloid leukemia (AML).

Original Article: Astex Pharma’s Leukemia Drug Fails Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "Astex Pharma’s Leukemia Drug Fails Clinical Trial"

Advertisement
Quick Search
Advertisement
Advertisement